Regarding the need, or lack thereof, of a comparator group for pregnancy registries
- 23 June 2009
- journal article
- other
- Published by Wiley in Birth Defects Research Part A: Clinical and Molecular Teratology
- Vol. 85 (9) , 808
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Measurements of birth defect prevalence: Which is most useful as a comparator group for pharmaceutical pregnancy registries?Birth Defects Research Part A: Clinical and Molecular Teratology, 2009
- Validation of neural tube defects in the full featured—general practice research databasePharmacoepidemiology and Drug Safety, 2008
- Data Resources for Investigating Drug Exposure during Pregnancy and Associated OutcomesDrug Safety, 2008
- Evaluation of the general practice research database congenital heart defects prevalence: Comparison to United Kingdom national systemsBirth Defects Research Part A: Clinical and Molecular Teratology, 2007
- Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy RegistryPharmacoepidemiology and Drug Safety, 2004
- Systematic Identification of Drugs That Cause Birth Defects — A New OpportunityNew England Journal of Medicine, 2003